Low Level Light Therapy & Skin Pigmentation
Part of paid clinical trials in Houston, Texas.
- Sponsor
- University of Houston
- Study ID
- NCT07173530
- Status
- Recruiting
Conditions
- Dry Eye
- Meibomian Gland Dysfunction (Disorder)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Three 15-minute low-level light therapy sessions using Light Emitting Diodes of wavelength 633nm (Essilor epi-c plus). — DEVICEA mask with Light Emitting Diodes wavelength 633nm will be placed over closed eyes for 15 minutes.
Study Details
The goal of this clinical trial is to determine if there is a difference in eyelid temperature after low-level light therapy (LLLT) in individuals with different amounts of skin pigmentation and dry eye/meibomian gland disease. Participants will have 3 fifteen minute in office LLLT therapy sessions over a period of approximately 7 to 14 days.
Key Dates
- Start date
- Jun 11, 2025
- Status verified
- Jul 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Fitzpatrick skin tone I-IVIndividuals with skin tones I-IV on the Fitzpatrick scale will receive low-level light therapy
- Experimental: Fitzpatrick skin tone V-VIIndividuals with skin tones V-Vi on the Fitzpatrick scale will receive low-level light therapy
Primary Outcome Measure
Eyelid temperature [ Time Frame: Eyelid temperature will be measured before and after 15 minutes of low-level light therapy at the baseline visit. ]
Central Contacts
- Eric Ritchey, OD, PhD713-743-1933
- Rachel Redfern, OD, PhD713-743-1943
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Houston College of Optometry | Houston | Texas | 77204 | Eric Ritchey, OD, PhD (PRINCIPAL_INVESTIGATOR) Rachel Redfern, OD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational StudyRecruiting · Neuro-Ophthalmology of Texas · Houston, Texas
- Penn SICCA Follow-up StudyNot Yet Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune DiseasePHASE4 · Recruiting · Toyos Clinic · Nashville, Tennessee
- Quality of Life in Presbyopic Patients Who Are Treated With QlosiPHASE4 · Recruiting · Southern College of Optometry · Medina, Minnesota